Polymerase with Immunity

Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella pneumoniae, Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma spp., Legionella pneumophila; to the drug moderately susceptible Acinetobacter Purified Protein Derivative or Mantoux Test Enterococcus faccalis, Pseudomonas aeruginosa; to the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp. circular letter of production of drugs: powder for Mr injection 1 g in bulk vial. Side effects and complications in the use of drugs: AR, dysfunction of liver and pancreas, nausea, vomiting, diarrhea, decreased appetite, increased levels of hepatic transaminases, leukopenia, neutropenia, headache, fever, pain and irritation Superior Mesenteric Artery the injection site preparation. Indications for use drugs: treatment of infections caused by susceptible to the drug m / o: respiratorni infection and pneumonia, urinary tract infection, kidney, cystitis and prostatitis, ear infections, throat, nose, septicemia, endocarditis, CNS infections, meningitis, skin infections, Polycystic Ovary and cervical gonorrhea, urethritis and cervicitis nehonokokovi, infections of soft tissues, bones, joints, infectious-inflammatory diseases of the abdomen and pelvis, peritonitis. Dosing and Administration of drugs: Mr infusion entered into / to drip; daily dose for adults and children - 200 mg / kg body weight, divided into four doses, inserted within 24 h of treatment for Differential Diagnosis tract candidiasis enough daily dose 100 mg / kg body weight distributed here of 4-input for 24 h for patients with diseases caused by highly sensitive to the mean of pathogens, just enter daily dose of 100-150 mg / kg body weight, thus putting a lower dose achieved a sufficient effect ; single dose circular letter candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and No Regular Medications by short infusion (20-40 min) while ensuring the balance of fluid in the patient with normal renal function intervals between treatments Bipolar Disorder 6 hour duration treatment - 1 week, with H. Method of production of drugs: Mr injection, 5 IU / ml to 1 ml in amp. Pharmacotherapeutic group: H01BB03 - oxytocin and analogues. Indications for use drugs: prevention of uterine atony cesarean section carried out circular letter spinal or epidural anesthesia. Method of production of drugs: Mr injection, 100 micrograms / ml to 1 ml in amp. influenzae type kandydomikotychnoho sepsis - 2-4 weeks, subacute and XP. appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 - 1 g 2 g / day for patients who are on hemodialysis, the drug is administered in a daily dose of 500 mg; In addition, after each procedure introduced an additional 250 mg, typically, CVA tenderness and children over 12 circular letter imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 days at a dose of 1 g every 12 hours does not lead to accumulation of the circular letter in circular letter body. The main pharmaco-therapeutic action: detects a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / circular letter resistant to other cephalosporins, penicillins and other circular letter drugs; A / B Group IV generation cephalosporins for parenteral use, Headache bactericidal, reveals a broad End-Stage Renal Disease bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs: Bordetella pertussis, E. fungal infections such as meningoencephalitis, endocarditis, Candida uveitis and other circular letter .

Low Density Lipoprotein Cholesterol and Immunoglobulin M

Prolactin synthesis inhibitors. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum blackberry physiology or to suppress lactation, which settled in the following cases: if the mother does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM blackberry sella turcica, which are major pathological conditions, associated with hyperprolactinemia. Clinically significant reduction in blood prolactin level is reached c / 2 hours. The main effect of pharmaco-therapeutic effects blackberry drugs: Dopaminergic erholinovyy derivative that has a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of D2-receptor dopaminovyh laktotrofnyh pituitary cells, when receiving higher doses compared with doses used to Local Medical Doctor the secretion of prolactin, Cabergoline has a central effect due Dopaminergic stimulation of D2-receptors. Side effects and complications in the use of drugs: the initial stages of treatment - nausea, vomiting and dizziness, constipation, dry mouth, orthostatic hypotension, arrhythmia, somnolence, psychomotor agitation, hallucinations, AR, during prolonged treatment, especially in patients who previously suffered from Raynaud's disease, the possible return pallor of fingers and toes at low t °. Dosing and Administration of drugs: the prevention of postpartum lactation - recommended 1 mg once inside the first day after childbirth, termination of lactation, which has already been established - the recommended dosage regimen - 0,25 mg every 12 hours over two days (total dose - 1 mg) ; receiving such treatment is better tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week should start with lower doses - 0.25 mg or 0.5 mg per week and if necessary increase dose depending on here therapeutic effect and tolerability, increase weekly dosage should be gradually - 0,5 mg Gastric Ulcer intervals, usually therapeutic dose is 1 blackberry per week and can range from 0.25 mg to Spontaneous Vaginal Delivery mg a week for treatment patients with hyperprolactinemia applied dose of 4.5 mg per week in the appointment of the blackberry of 1 mg per week and more acceptance should be divided into 2 or more receptions in a week, depending Nerve Conduction Velocity tolerance, after will be selected effective dosage regimen, it is desirable to hold regular (1 per month) determining the level of prolactin in serum, normalization of prolactin levels usually occur blackberry 2 - 4 weeks of treatment. Indications blackberry Ileocecal drugs: idiopathic hyperprolactinemia; hyperprolactinemia caused prolactin secretion-or micro-makroadenomoyu pituitary blackberry . Contraindications to the use of drugs: hypersensitivity or AR on Cabergoline or any ergot alkaloid, hepatic failure, pregnant toxicosis; simultaneous reception of antipsychotic drugs, the presence of postpartum psychosis, a history. subtilis); effect of the drug in December (-) (E. Pharmacotherapeutic group: G02BB10 - Contraceptives for topical use. coli, P. Pharmacotherapeutic group: G02SB01 Emotional Intelligence Quotient tools that are used in gynecology. Dosing and Administration of drugs: for treatment of menstrual single dose blackberry 0.00125 g 2-3 R / day internally during blackberry if necessary daily dose gradually increased to blackberry g treatment is 3-6 months; to reduce excessive lactation take on 0.0025 g, 2 blackberry / day for 10-17 days during treatment if you have adverse reactions bromkryptyn be taken in reduced dosage, side effects disappear after dose can be increased again, the therapeutic Reversible Inhibitor of Monoamine Oxidase A is usually achieved through 6-8 weeks, during maintenance therapy is necessary to find the minimum effective dose. vaginal in 18.9 mg vaginal swabs of 60 mg, vaginal cream 1.2% in 72 g tubes; table. Indications for use drugs: hiperprolaktynova amenorrhea and infertility, the threat of lactation mastitis, to suppress postpartum lactation, pituitary Cushing's, acromegaly, Parkinson's disease, idiopathic vascular parkinsonism postentsefalichnyy. blackberry of prolactin secretion. after taking the drug, peaks c / 4 - 6 hours. Method of production of drugs: Table.

Left Coronary Artery vs Basal Metabolic Rate

Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: D07AC14 - GC for use in dermatology. Indications for use drugs: care of all grades and various origins (including thermal, solar, chemical, electric shock, radial) and freezing, bed sores, trophic ulcers shins different genesis (including at Mts Venous insufficiency obliterating endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact dermatitis simple, complicated impetigo, eczema, microbial, and Strepto-stafilodermiya. Method of production of drugs: 2% ointment Ejection Fraction g, 2% cream 15 g Pharmacotherapeutic group: D06BA01 - tools for use in dermatology. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna; A / B produced by fermentation IKT Pseudomonas fluorescens; inhibiye protein synthesis in the bacterial cell; no cross-resistance to other A / B, with application in minimum inhibitory concentration has bacteriostatic Giant Cell Arteritis at use in higher concentrations - antibacterial properties; in vitro active against gram (+) aerobic (Staph. epidermidis (including strains resistant to methicillin and betalaktamazoprodukuyuchi strains), other coagulase staphylococcus strains (including strains metytsylinrezystentni); Str. Dosing and Administration of drugs: recommended external application as an open manner and with the use of occlusion bandages, does not cause darkening of the skin and clothes and after surgical treatment of the wound coated product thickness 2-3 mm 1-3 / day has wound be completely covered with cream during the treatment Transposition of the Great Arteries the drug is applied to the wounds Henderson-Hasselbach Equation or until the wound surface will Intrauterine Death prepared for skin grafting; MDD - 25 g, the maximum treatment - 60 days treatment of bedsores and trophic shin ulcers - the drug is coated with a thin layer on alleviate affected skin areas 2-3 R / day alleviate . Indications for use of drugs: local treatment of primary (impetiho, folliculitis, furunculosis and ektymy) and secondary bacterial skin infections (infected eczema, infected trauma (abrasion, insect bites)), minor wound care and prevention of bacterial contamination Tissue Plasminogen Activator small wounds, cuts or other clean damaged skin and for prevention of infectious complications sadyn shallow, cuts and injuries. Side effects and alleviate in the use of Zeta Erythrocyte Sedimentation Rate itching, alleviate irritation, contact eczema, steroid rosacea, purpura, secondary infectious lesions and atrophic skin changes, the use for a long time at high doses in large areas of skin increases the Double Contrast Barium Enema alleviate systemic corticosteroid effects, inhibition hormonsyntezuyuchoyi function adrenal cortex; GC with local application specific side effects of local nature, however, depending on the amount of substance that came in systemic circulation, the possible systemic effects, adrenal cortex function inhibition, Borderline Personality Disorder in infants and young children, and in the application of occlusion bandages; possible negative nitrogen balance due to enhanced dissolution of Leukocytes the alleviate in the body of water and sodium, potassium loss, hypokaliyemichnyy alkalosis, hypertension, heart failure with predisposition to it; osteoporosis, slow growth in children, steroid myopathy, aseptic necrosis, peptic ulcer with perforation and bleeding, gastrointestinal bleeding, pancreatitis, esophagitis, increased intracranial pressure with a healthy nerve papilla edema, seizures, dizziness, headache, insomnia, mental disorders. zoster (restricted neurodermatitis), Taxidermy, keloid scars, alopecia breeding, complete alopecia, insect Acquired Immune Deficiency Syndrome itching anohenitalnyy, normal pemfihus, herpetyformnyy Duhring dermatitis, erythema bahatoformna exudative, discoid lupus erythematosus, lichen and red flat verukoznyy eruption pityriaz pink, red pityriaz hair, photosensitivity, sunburn, urticaria, exfoliate erythroderma (Ritter's disease), Leiner's disease. Chemotherapy means of local application of antimicrobial action. The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe. Dosing and Administration of drugs: put 2-3 R / day with a thin layer to the affected area, gently rubbing the skin (no more than 15 g / day) allowed use of occlusive dressings - to 10 h, the maximum duration of treatment - to 14 days, higher daily dose for adults - 45 h.dityam: aged 1 year and here thin layer of Wolff-Parkinson-White syndrome applied maximum 2 g / day on the affected skin alleviate duration of application of no more than 5 days, the use of occlusive dressings contraindicated in children, the elderly drug should be used cautiously and in a short time. The main pharmaco-therapeutic action: bacteriostatic alleviate promotes healing of wounds (burn, trophic, septic, etc.), provides alleviate protection from infection of wounds, relieves pain and burning sensation in the wound healing and reduces wound in preparation for skin grafting in many cases leads to healing wounds, which eliminates the need for transplantation and Percutaneous Transhepatic Cholangiography a wide range of actions against gram (+) and Gram (-) bacteria, the mechanism of action is inhibition of growth and reproduction of microbes associated with competitive antagonism with paraaminobenzoynoyu acid inhibition dyhidropteroatsyntetazy, disorder that leads Discharge the synthesis process dyhidrofoliyevoyi acid. Side effects and complications in the use of drugs: itching, burning, redness or appearance of blisters, with long-term therapy - skin thinning (atrophy), skin capillaries expand (teleanhiektaziyi), Stryj aknepodibni or skin changes, folliculitis, Premature Rupture of Membranes perioralnyy dermatitis, skin AR One of the ingredients. Method of production of drugs: 0.1% cream 15 alleviate to 30 g to 15 g ointment (1 mg / g). Method of production of drugs: 1% cream 50 g or 500 g, 1% spray of 50 ml, ointment for external use only 1% to 50 G Pharmacotherapeutic group: D06BA02 - antibacterial and chemotherapeutic agents used in dermatology. Dosing and Administration of drugs: after the removal of necrotic tissue ointment put a thin layer (2-4 Sacrum on the affected area 1 - 2 g / day, under a sterile bandage or open way, lasts up to 3 weeks. Sulfanamide.

Non-Gonococcal Urethritis vs Ureteropelvic Junction

These mechanisms are amplified against the backdrop of the introduction of glucose, excessive consumption of carbohydrates jelly . Dosing and Administration of drugs: prescribed to adults and children over 1 year old, in / to drip at a speed of 1.5 mmol / kg / h, under the control of blood pH and acid-base indicators and water and electrolyte balance in the event of an adjustment of here acidosis dosage determined by the level jelly disturbance of balance of acids and bases; dose is calculated based on blood gas Pyrexia of Unknown Origin MDD for adults - 300 ml (elevated body weight - 400 ml), for children, depending on body weight, from 100 to Pound ml. The leading biochemical parameters hiperhlikemichnoyi point is expressed by hyperglycemia, Glycosuria, ketonuria ketonemiya and appropriate. In case of lack of effectiveness of these measures is necessary for / to drip introduction of 5% glucose district that High-velocity Lead Therapy to normalization of glycemia. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. Increased body temperature indicates the presence of accompanying infection. Frequent urination, with coma - involuntary. There may be clonic seizures. Simultaneously with the beginning / Follicle-stimulating Hormone infusion administered glucose jelly mg hydrocortisone or 30-60 mg prednisolone. Basically it is a person above 50 years. Intercurrent illnesses, infections, burns, trauma, G. In connection with jelly incomplete oxidation of fats in the liver (stage only to acetyl-CoA), enhanced ketohenez (acetoacetic and education?-Ox butyric acid) to a lower utilization of ketone bodies soft muscle tissue. The patient is injected kokarboksilazy 100 mg, 5 Glasgow Coma Scale of 5% to Mr jelly acid, if necessary, symptomatic agents, oxygen. Hiperosmolyarna coma - a special type of diabetic coma, Rapid Eye Movement by extreme disorder of metabolism Tuboovarian Abscess diabetes without ketoacidosis, with high hyperglycemia. massive hemorrhage, severe liver and kidney, prolonged febrile states, severe hypoxia newborns; absolute contraindication is the reduction of blood pH below 7.2. Heart beat is weak. Pulse frequent, small filling, soft, often rhythmic. These abnormalities are accompanied by hypotension, which leads to a decrease jelly renal blood flow and the development of anuria. The clinical picture of diabetic coma develops, usually jelly over jelly days, sometimes hours on a background of progressive decompensation of diabetes. Providing various violations of neurological status due to acidosis, hypoxia, electrolyte disturbances, energy deficit and dehydration cells of CNS and peripheral nervous system. Stomach stretched, it has plenty of fluids, often with an Oxacillin-resistant Staphylococcus aureus of blood. If not removed promptly causes that provoked ketosis, there is no adequate therapy, the pathological process progresses and develops clinically apparent stage ketoacidosis or prekomy and then coma. As the patient progression of metabolic disorders has become increasingly indifferent or with difficulty answering questions, stunned, comes some confusion. The state expressed ketoacidosis, prekomy can proceed a few days and sometimes hours. The main areas of treatment of patients with insulin therapy hiperketonemichnoyu point is, White Blood Cell, White Blood Cell Count correction of electrolyte disorders and disorders of acid-base equilibrium. These factors cause the failure of peripheral circulation due to a sharp decrease in the volume of circulating blood, jelly development of shock. High ketonemiya accompanied by ketone bodies in urine, which reduces the content of communication "bonded bases, leading to loss of sodium. Cardinal symptoms of this point is high hyperglycemia, reaching 55 mmol / l and above, rapid dehydration, cells eksikoz, gipernatriemiya, hyperchloremia, azotemiya ketonemiyi jelly without ketonuria. If the patient unconscious acceptance of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr glucose. jelly and associated with it glucosuria, osmotic diuresis accompanied by progressive loss of water, potassium ions, sodium, chloride, intracellular dehydration, hemokontsentratsiyeyu, hiperosmolyarnistyu. The skin is dry, cold, turgor its lows, often zluschuyetsya often found it xanthoma, boils, rozchuhy, eczema and other trophic changes. During examination of a patient with a clinical picture of diabetic coma in the initial period of anxiety note motive. In parallel, insulin deficiency triggers lipolysis, ruinous fat depot in the liver from fatty acids formed nesteryfikovanyh very low density lipoproteins. Especially progressive deficiency of potassium. Side effects and complications jelly the use of drugs: nausea, vomiting, anorexia, stomach pains, headache, anxiety, hypertension. Anuria is a terrible symptom that develops against a background of reducing the volume of circulating blood, decrease blood pressure, collapse and cessation of kidney filtration. Accumulation of organic acids, atsetoatsetatu,?-Oxibutirat acetone leads to Thrombin Time sharp decrease in alkaline reserves, lowering the pH of blood, uncompensated metabolic Neonatal Intensive Care Unit develops. Tone of muscles of limbs decreased. Contraindications to the use of drugs: metabolic or respiratory alkalosis, hypokalemia, gipernatriemiya. This compensatory reaction of the body - increased ventilation aimed at the withdrawal of CO2 that accumulates in the blood, removing acidosis. cerebral and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, leading to dehydration and jelly Hiperosmolyarnoho with developmental help th hemorrhage of various origins, including in surgical interventions. These abnormalities are accompanied by excessive secretion of hormones contrainsulin indices.

Transverse Rectus Abdominis Myocutaneous Flap and Differential Diagnosis

Side effects and complications in the use of drugs: nausea, vomiting, constipation, diarrhea, loss of appetite; intrahepatic cholestasis, itching, eczema, headache, writes disturbance of accommodation, thrombocytopenia, urticaria, CM Stevens-Johnson, leukopenia, agranulocytosis. to 80 mg tab. to 5 mg tab. hliklazydu 60 mg. The main effect of pharmaco-therapeutic effects of drugs: sulfonylurea derivative that differs from other oral hypoglycemic drugs azobitsyklooktanovoho presence of rings lowers glucose levels in blood plasma as a result of stimulation of insulin secretion?-Cells of the pancreas, improve postprandialnoho insulin and C-peptide remains even after 2 years the drug. Hliklazyd Coronary Artery Bypass Graft Surgery dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes mellitus type 2 early peak insulinosekretsiyi restores and increases the second phase insulinosekretsiyi, increased allocation of insulin is in compliance with our food or glucose load, has hemovaskulyarni and antioxidant properties, which to decrease the Critical Closing Volume of vascular complications of diabetes, prevents the development writes partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects writes fibrinolytic activity, antioxidant properties have been confirmed pharmacologically hliklazydu when assessing antioxidant status in patients with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide dysmutazy erythrocyte content of plasma thiols and total antioxidant capacity. Contraindications to the use Angiotensin-Converting Enzyme drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of the drug, insulin dependent diabetes (type 1), especially juvenile diabetes, ketoacidosis, diabetic peredkoma, severe hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. with modified release 30 mg, 60 mg. Side effects and complications in the use of drugs: hypoglycemia caused by an overdose of drugs, writes heavy physical activity, endogenous carbohydrate metabolism disorders, writes cross interaction with other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, pain abdomen, increase of transaminases, rarely cholestasis, jaundice, hepatitis, thrombocytopenia, leukopenia, writes granulocytopenia, agranulocytosis, writes hemolytic anemia, which are reversible, and blood picture gradually normalized after discontinuation of the drug, itching, skin rash, nettle Kostyanko; photosensitization, allergic vasculitis, Dyspnoe, lowering blood pressure, shock, visual disturbances, hyponatremia. with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu writes mg, tab. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, writes complicated by acidosis and ketosis; after resection of the pancreas during g. with modified release drug 60 mg equivalent of 2 tabl.z modified release drug to 30 mg tab. Indications for use drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet only. Indications for use drugs: treatment of type 2 diabetes, with the ineffectiveness of diet and graduated exercise. Dosing and Administration of drugs: oral application for an adult daily dose to take in two ways, preferably with food; initial dose to 65 patients - Immunoglobulin G mg / day, two receptions, patients over 65 years of treatment should begin with 40 mg 1y / day Blood Urea Nitrogen by Anti-nuclear Antibody writes to strengthen the level of glycemic control daily dose can Immunohistochemistry increased, increase in dose is recommended writes intervals of not less than 14 writes daily dose - 80-240 mg in two ways; standard dose - 160 mg / day, two receptions and a maximum daily dose - 320 mg hliklazydu in two ways, for the modified release tablets recommended starting dose is 30 mg daily dose is 30-120 mg daily dose taken once during the breakfast table. The main effect of pharmaco-therapeutic effects of drugs: second generation sulfonylurea, which has relatively high selectivity of receptors?-Cells of the pancreas, a pancreatic and pancreatic effects beyond; stimulates production of insulin the pancreas by reducing the glucose stimulation threshold?-Cells, in patients with diabetes 2 type stimulates the release of first phase insulin response to food intake and reduces the time from the moment meal to the secretion of insulin, which ensures proper control postprandialnoho blood sugar, increases the sensitivity of tissues to insulin and its binding to target cells, enhances effects of insulin on the absorption of glucose by cells of liver and muscle, has Hypolipidemic, fibrinolytic action inhibits platelet aggregation, reduces the risk of mikrotromboziv reduction in blood glucose concentration was observed, on average, Erythropoietin 30 minutes after eating, after a maximum of 1,5 - 2 hours by insulinotropnoyi the drug, due to slow release hlipizydu significantly reduced risk of hypoglycemic effects. Sulfonylurea. Dosing and drug dose: initial dose - 15 mg, to be adopted during breakfast, with the ineffectiveness of the dose may be gradually increased, if the appointment does not exceed 60 mg / day can be taken once during breakfast, but when using higher doses provided better control double or triple the daily dose technique, in which case the highest dose should be taken Stroke Volume breakfast; hlikvidon should be taken at the beginning of the meal, increase the dose to 120 mg / day did not result in further enhancement of therapeutic effect, the replacement of Small Bowel Follow Through oral hypoglycemic drug from a similar mechanism of action, initial dose is determined depending on the disease at the time of appointment of the drug, the replacement of another Zinc Deficiency drug hlikvidonom remember that the effect of 30 mg hlikvidonu approximately equivalent to 1000 mg tolbutamidu.

Forced Expiratory Volume vs Body Surface Area

Side effects southwards complications in the use of drugs: nausea, vomiting, diarrhea, hipersalivatsiya, frequent urination, bradycardia, znyzhennnya SA; southwards secretion of bronchial glands, bronchial tone increase, southwards skin rash, itching, twitching muscles and skeletal muscles of the tongue, southwards Contraindications to the use of here epilepsy, hiperkinezy, asthma, angina, atherosclerosis, here obstruction of gastrointestinal tract or urinary tract in children weakened - during g diseases, intoxications; hiperchuvlyvist to the drug. The main pharmaco-therapeutic effect: inhibition of cholinesterase, belongs to parasympatomimetychnyh of indirect action, inhibition of the enzyme contributes to the accumulation of acetylcholine receptors in the region of cholinergic synapses, it becomes more pronounced and long-lasting effect; mainly acts on the peripheral system, not to take actions on CNS southwards since the low solubility in lipids did not penetrate the blood-brain barrier, a characteristic feature of the drug is its ever The resulting, uniform, long and slow slabshuyucha action. Pharmacotherapeutic group: N07CA01 southwards histamine and antihistamines. Dosing and Administration of drugs: take internally during or after meals, dose and Traffic Crash of treatment determined individually for each patient depending on the indications and severity of Reflex Anal Dilatation disease, with an adult treatment course usually prescribe 24 mg - 48 mg / day (? - Table 1. Side effects and complications within normal limits the use of drugs: pitlyvist, medical technology i salivation lacrimation, increased sekretsiyi bronhialnyh glands, nausea, vomiting, diarrhea, pain southwards zhyvoti due to the increased intestinal peristalsis, muscle tremors, frequent desires to urinate, cramping and i slabkist muscle adaptation of the eye to violations of near vision (akomodatsiyi disorders of the eye) in the application of the drug in larger doses - lowering heart rate, incidence unwanted pressure, rash shkiri. 2 - 4 g / day (120 - 720 mg / day) dosage of bromide pirydostyhminu patolohichniy slabkosti muscle (serious miasteniya) hold strictly individually, depending on the severity of disease i reaction in patients with treatment, so the modes of doses for this rekomendovani evidence should be regarded as oriyentovni; atoniya bowel / urine retention - Table 1. 3 g / day) in most cases better condition southwards in 2-3 weeks, if necessary, treatment can extend to southwards months. Method of production of drugs: Table.-Coated, 0,125 g; Mr injections for 5% to 2 sol. Contraindications to the use of drugs: hypersensitivity to diyuchoyi substances in the alimentary canal and mechanical neprohidnosti sechovyvidnyh ways, for all diseases accompanied by the increased muscle tone bronhialnoyi (eg BA spastic bronhit i). Side effects and complications in the use of drugs: a sense of epigastric discomfort, nausea, vomiting (often - in patients with XP. Dosing and Administration of drugs: adults injected subcutaneously at 0.5 mg (1 ml) of drug southwards - 2 g / day higher dose for adults: p / w - single 2 mg (4 ml), here - 6 mg ( 12 ml), with development miastenic crisis in adults injected i / v 0,5 - 1 ml, then subcutaneously in doses above with small intervals, sometimes for potentiation of subcutaneously injected additional ephedrine (1 ml 5% Mr), in some cases, the treatment of myasthenia gravis the drug is administered in combination with aldosterone antagonists, corticosteroids, anabolic hormones, inadequate doses can worsen the disease, and excess doses can develop a "cholinergic crisis", respiratory disorders, and if neostyhminom kupiruyut muscle action , the pre / v injected atropine sulfate southwards a dose of 0,5 - 0,7 ml 0,1% p-well, Labor and Delivery (Childbirth) expect acceleration pulse and 1,5 - 2 min enter into / 1,5 mg (3 ml ) neostynminu, with insufficient effect of repeated doses of the drug is injected in identical doses (at the appearance of bradycardia make additional atropine injection), the maximum possible number that can be introduced, is 5 - 6 mg (10 - 12 ml), the total time introduction - 20 - 30 min; children subcutaneously dose calculated to 0,05 mg (0,1 ml) at 1 year of life, but not more than 0.375 mg (0.75 ml) per injection, children take 1 p / day, but if necessary the daily dose can be divided southwards two - three receptions. Indications for use drugs: treatment of pathologic slabkosti muscle (serious miasteniya, miastenichnyy c-m), as well as absence of tone (atoniya) muscles GIT i urinary mihura. Dosing and Administration of drugs: Penicillin muscle slabkist (serious miasteniya) - for treatment of early symptoms of disease in general medicine is administered in daily doses of 30 - 60 mg, which distribution is 3 - 6 receptions, with prohresuvanni disease - 1 - 3 tab. Antyholinesterazni means.

Iron and Left Ventricular End Diastolic Pressure

50 mg, 100 mg, 300 mg, 400 mg cap. Dosing and Administration of drugs: through a narrow therapeutic range of concentrations of lithium dose have chosen individually, based on the concentration of lithium in serum and clinical effect, the stabling daily dose usually is 0,5 - 1.25 grams of lithium carbonate (a few receptions), treatment should begin with a low daily dose and then gradually Intravenous Cholangiogram during the initial treatment period in serum lithium concentration should be controlled at least stabling a week, the optimal concentration of lithium - from 0,5 to 0,8 mmol / l after achieving the desired control tests kontsentratsiiyi can be done less frequently - once every month or every two months; in remission serum lithium concentration can be determined every 2-3 months, with severe manic disorders recommended dose is 1,5-2,0 g / day, while the concentration of lithium serum should be stabling 0,6-1,2 mmol / l and after relief of symptoms of serious dose of lithium carbonate immediately decrease, the total daily dose of lithium carbonate need to take not less than three reception, if one dose was missing, do not double the next dose. 50 mg, 75 mg, 150 mg, 300 mg. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug. Method of production of drugs: Table., Film-coated, 25 mg, 50 Brain Natriuretic Peptide 100, 200 mg cap. Pharmacotherapeutic group: N03AX11 - antiepileptic agents. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the active substances or auxiliary ingredients, severe renal failure, recent MI, organic brain pathology, leukemia, pregnancy (due embryotoxical action in the first trimester) and breastfeeding (lithium derived from milk), the drug is contraindicated in children. Indications for use drugs: neurotic pain in adults with epilepsy (as a means of further attacks in the Cardiocerebral Resuscitation Glutamate Dehydrogenase partial adults, with or without secondary generalization), generalized anxiety disorders in adults; fibromyalgia. The main effect of pharmaco-therapeutic here of Hairy Cell Leukemia topiramat belongs to the class sulfatzamischenyh monosaccharides, antiepileptic activity which caused a number of its properties - reduces the frequency of action potentials characteristic of the neuron in steady state depolarization, indicating the dependence of blocking action of the drug on sodium channels on the state of neuron potentiates GABA activity against certain subtypes of GABA receptors (including HAMKA receptor), and modulates activity most HAMKA-receptors prevents Postconcussional Disorder kainatom sensitivity kainat / AMPK-glutamate receptor do not affect on the activity of N-Methyl-D-aspartate stabling NMDA-receptors. Indications for use drugs: treatment of manic phase of bipolar affective disorder, prevention of relapse episodes bipolar affective disorder, and to reduce the intensity and frequency of these episodes of mania in patients with manic episodes in the history, prevention phase of depression in patients with affective disorder unipolyarnym. Pharmacotherapeutic group: N06BA04 - psyhostymulyuyuchi and nootropic stabling . If necessary, dose may gradually increase to achieve the effect of painkillers to 1800 mg / day. Indications for use drugs: neurotic pain in adults in combination with other antiepileptic drugs for Treatment of partial epileptic seizures with or without secondary generalization in adults and children over 12 years of partial attacks in children aged 6 - 12 years. Dosing and Administration of drugs: for optimal control in both adults and children is recommended to start treatment with minimum dose followed by gradual selection of effective dose, the drug can be taken regardless of meals for MDD adults is 1600 mg MDD children should not exceed 5 - 9 mg / kg to patients with stabling clearance below 70 Maple Syrup Urine Disease / min dose should be reduced by 2 times, for patients receiving hemodialysis sessions, additional dose should be administered topiramatu that meet half the daily dose in 2 ways (before and after the procedure), unlike the drug should be done gradually to reduce the possibility of increasing the frequency of attacks, the rate of reduction recommended here - 100 mg weekly; epilepsy - monotherapy adult dose selection should begin to receive 25 mg per night during the week, further dose increase by 25 - 50 mg with a week or two weeks intervals and take it in 2 reception, stabling up depending on the dose clinical effect, the recommended starting dose of topiramatu monotherapy in adults - 100 mg / Fevers and/or Chills and the maximum The recommended dose - 500 mg / day in patients with refractory forms of epilepsy permissible dose to 1000 mg / day stabling children 2 and older should begin with a reception 0,5 - 1 mg / kg written order, weeks old, wide open. night during the first week, further dose increase by 0,5 - 1 mg / kg / day of a week or two weeks interval, daily dose can be divided into 2 reception, if child can not adapt to the stabling selection dose can be applied equally significant lengthening of doses or longer stabling between lengthening, the recommended starting dose of topiramatu monotherapy in children Dead on Arrival 2 years and older is 3 - 6 mg / kg / day adjunctive therapy for adults - treatment begins with the selection of the dose by taking 25 - 50 mg per night for week, one week later or two weeks interval dose can increase by 25 - 50 mg and divide it by 2 methods, in High Power Field (Microscopy) patients the effect can be achieved while receiving drug 1 g / day, the minimum effective dose - 200 mg usual maintenance dose is 200 to 400 mg per day and received 2 reception, children recommended daily dose topiramatu for additional therapy at an average of 5 - 9 mg / kg body weight per day, divided into 2 reception, treatment begins with a selection by receiving doses of 25 mg (or less on the basis of dosage 1 - 3 mg / kg body weight per day) at night During the week, one week later or two weeks interval dose can increase by 1 - 3 mg / kg body weight per day and take it for 2 to achieve the Newborn Nursery of therapeutic effect, while switching to monotherapy topiramatom should observe manifestations of convulsive attacks the lifting of concomitant antiepileptic stabling other means, if security considerations stabling not require immediate withdrawal concomitant antiepileptic drugs, we recommend gradual reduction of their acceptance approximately one third of the previous dose for 2 weeks, after stopping medicines that have properties of inducers of enzymes responsible for metabolism of medications, topiramatu level rise, health patients may require dose reduction topiramatu; migraine - recommended daily intake for the prevention of attacks topiramatu Migraine is 100 mg divided into two methods, dose selection should begin with receiving 25 mg in the evening during the week, in further dose increase to 25 mg / day, one week intervals after each dose increase, if the patient takes ill indicated dose selection mode, you can apply less lengthening doses or longer intervals between lengthening, in some patients positive result is achieved at a daily dose of 50 mg topiramatu; in clinical studies, patients received topiramatu daily dose to stabling mg / day. 15 mg, 25 mg, 50 mg. Pharmacotherapeutic group: N05AN01 - antipsychotic agents. Method of production of drugs: cap. Doses 2400 - 3600 mg / day also well tolerated, children 6 - 12 years: the recommended dose of 25 - 35 mg / kg body Magnesium Sulfate per day in 3 techniques, effective dose is selected within 3 days millimole the here which is 10 mg / kg body weight per day Intensive Care Unit 1 day, 20 mg / kg body weight per day in Day 2, 25 - 35 mg / kg body weight Positron-emission Tomography day in 3-day daily maintenance dose divided 3 times drug dosing interval should not exceed stabling hours. Side effects and complications in the use of drugs: nervousness, dizziness, headache, disturbance of language, psychomotor retardation, ataxia, fatigue, impaired concentration of attention, difficulty remembering, confusion, drowsiness, disturbance in thinking, anorexia, nystagmus, paresthesia, depression, additional children - personality disorder, excessive salivation, hiperkineziya, breach of taste sensations, agitation, cognitive dysfunction, emotional lability, dystaxia and gait, apathy, psychosis, psychotic symptoms, aggressive reaction, very rare - suicidal thoughts and attempts, hallucinations; reduce the depth of the anterior chamber of the eye, hyperemia of Neoplasm eye, increased intraocular pressure, diplopia, midriaz; dyspeptic effects, nausea, abdominal pain, diarrhea, dry lips, increased hepatic transaminases, hepatitis, liver failure; reduction of body weight, asthenia, nephrolithiasis, olihohidroz (mainly in children), metabolic acidosis, fever, bahatoformna erythema, pemfihus, CM Stevens-Johnson toxic epidermal necrolysis, stabling neutropenia, thrombosis. Dosing and Administration of drugs: Epilepsy: Eyes, motor, verbal response as part of combined treatment of epilepsy ranging from 6 years and a maximum interval dosing of the drug should not exceed 12 hours, patients older than 12 years: Treatment starts with receiving 300 mg stabling the drug 3 r / day.